Patent · US Active

Methods and compositions for modification of a HLA locus

US10072062B2 · kind B2 · utility

6Cited by

34References

11Claims

0Family size

Assignees

Sangamo Therapeutics, Inc. · US
The Board of Regents of the University of Texas System · US

Inventors

Trevor Collingwood · Chesterfield, US
Laurence J.N. COOPER · Houston, US
Philip D. Gregory · Richmond, US
Michael C. Holmes · Richmond, US
Jeffrey C. Miller · Pleasanton, US
Edward J. Rebar · Richmond, US
Andreas Reik · Richmond, US
Fyodor Urnov · Richmond, US

Key dates

Filing date	Jan 5, 2015
Grant date	Sep 11, 2018
Priority date	—
Expiry date	Jan 5, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/80
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for modulating the expression of a HLA locus or for selectively deleting or manipulating a HLA locus or HLA regulator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.